Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM221 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PLXNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AREL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ACTRT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFSF14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPCAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TM6SF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL36A-HNRNPH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GNA11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF221 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KHSRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHCTF1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2orf15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on